Human tissue is an important element in the growth of modern medication. Pharmaceutical firms lose millions of dollars every year to drug development failures. The research process requires human tissue from animal samples because it is more trustworthy for participants during clinical examinations and speeds up the drug development process.
Moreover, this saves money, and drug companies are willing to pay high prices for different types of cells, tissues, and organs to speed up their research. However, for performing a human tissue procurement visit https://www.geneticistinc.com/blog/why-human-tissue-procurement-is-so-important.
Image Source: Google
The development of a cystic fibrosis treatment is a great example of how drug testing for human tissue works. Scientists at the department observed the performance of infected human lung tissue on Petri dishes and then injected drugs into the cells to see how they responded. One of the things they look for is eyelash movement after treatment. None of this would be possible without the use of human tissue.
In the United States, most human tissue used in research comes from donors who have given consent and agreed to donate to pharmaceutical development companies after their death. They come completely from organ procurement organizations, hospitals, tissue banks, and other regulated sterile medical facilities. The demand from private and public research companies is unlimited, but the supply is limited.
Government funding and tissue donations make sense, but they can’t keep up with the growing demand in the human tissue market. Biomedical administrators have sprung up over the last decade with private firms whose founders are resolute about legal and ethical practice. Geneticists are passionate about contributing to this thriving community and participating in global efforts for a more sustainable human existence.